SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-001302
Filing Date
2015-05-15
Accepted
2015-05-15 14:20:01
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q entiabiosciences10q033115.htm 10-Q 773294
2 EX-31.1 ex31-1.htm EX-31.1 14079
3 EX-32.1 ex32-1.htm EX-32.1 4990
10 GRAPHIC logo.jpg GRAPHIC 14906
  Complete submission text file 0001185185-15-001302.txt   7136698

Data Files

Seq Description Document Type Size
4 EX-101.INS ergo-20150331.xml EX-101.INS 1170654
5 EX-101.SCH ergo-20150331.xsd EX-101.SCH 53851
6 EX-101.CAL ergo-20150331_cal.xml EX-101.CAL 28119
7 EX-101.DEF ergo-20150331_def.xml EX-101.DEF 288471
8 EX-101.LAB ergo-20150331_lab.xml EX-101.LAB 366872
9 EX-101.PRE ergo-20150331_pre.xml EX-101.PRE 288640
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52864 | Film No.: 15867905
SIC: 2833 Medicinal Chemicals & Botanical Products